Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Estradiol Transdermal System Market Size Growth Rate by Type
1.3.2 0.025 mg per day
1.3.3 0.0375 mg per day
1.3.4 0.05 mg per day
1.3.5 0.075 mg per day
1.3.6 0.1 mg per day
1.4 Market Segment by Application
1.4.1 Global Estradiol Transdermal System Market Share by Application (2018-2025)
1.4.2 Hot flashes
1.4.3 Prevention of postmenopausal osteoporosis
1.4.4 Treatment of hypoestrogenism
1.4.5 Moderate-to-severe vasomotor symptoms
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Estradiol Transdermal System Market Size
2.1.1 Global Estradiol Transdermal System Revenue 2013-2025
2.1.2 Global Estradiol Transdermal System Sales 2013-2025
2.2 Estradiol Transdermal System Growth Rate by Regions
2.2.1 Global Estradiol Transdermal System Sales by Regions 2013-2018
2.2.2 Global Estradiol Transdermal System Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Estradiol Transdermal System Sales by Manufacturers
3.1.1 Estradiol Transdermal System Sales by Manufacturers 2013-2018
3.1.2 Estradiol Transdermal System Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Estradiol Transdermal System Revenue by Manufacturers (2013-2018)
3.2.2 Estradiol Transdermal System Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Estradiol Transdermal System Market Concentration Ratio (CR5 and HHI)
3.3 Estradiol Transdermal System Price by Manufacturers
3.4 Key Manufacturers Estradiol Transdermal System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Estradiol Transdermal System Market
3.6 Key Manufacturers Estradiol Transdermal System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 0.025 mg per day Sales and Revenue (2013-2018)
4.1.2 0.0375 mg per day Sales and Revenue (2013-2018)
4.1.3 0.05 mg per day Sales and Revenue (2013-2018)
4.1.4 0.075 mg per day Sales and Revenue (2013-2018)
4.1.5 0.1 mg per day Sales and Revenue (2013-2018)
4.2 Global Estradiol Transdermal System Sales Market Share by Type
4.3 Global Estradiol Transdermal System Revenue Market Share by Type
4.4 Estradiol Transdermal System Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Estradiol Transdermal System Sales by Application
6 North America
6.1 North America Estradiol Transdermal System Breakdown Data by Company
6.2 North America Estradiol Transdermal System Breakdown Data by Type
6.3 North America Estradiol Transdermal System Breakdown Data by Application
6.4 North America Estradiol Transdermal System Breakdown Data by Countries
6.4.1 North America Estradiol Transdermal System Sales by Countries
6.4.2 North America Estradiol Transdermal System Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Estradiol Transdermal System Breakdown Data by Company
7.2 Europe Estradiol Transdermal System Breakdown Data by Type
7.3 Europe Estradiol Transdermal System Breakdown Data by Application
7.4 Europe Estradiol Transdermal System Breakdown Data by Countries
7.4.1 Europe Estradiol Transdermal System Sales by Countries
7.4.2 Europe Estradiol Transdermal System Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Estradiol Transdermal System Breakdown Data by Company
8.2 Asia Pacific Estradiol Transdermal System Breakdown Data by Type
8.3 Asia Pacific Estradiol Transdermal System Breakdown Data by Application
8.4 Asia Pacific Estradiol Transdermal System Breakdown Data by Countries
8.4.1 Asia Pacific Estradiol Transdermal System Sales by Countries
8.4.2 Asia Pacific Estradiol Transdermal System Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Estradiol Transdermal System Breakdown Data by Company
9.2 Central & South America Estradiol Transdermal System Breakdown Data by Type
9.3 Central & South America Estradiol Transdermal System Breakdown Data by Application
9.4 Central & South America Estradiol Transdermal System Breakdown Data by Countries
9.4.1 Central & South America Estradiol Transdermal System Sales by Countries
9.4.2 Central & South America Estradiol Transdermal System Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Estradiol Transdermal System Breakdown Data by Type
10.2 Middle East and Africa Estradiol Transdermal System Breakdown Data by Application
10.3 Middle East and Africa Estradiol Transdermal System Breakdown Data by Countries
10.3.1 Middle East and Africa Estradiol Transdermal System Sales by Countries
10.3.2 Middle East and Africa Estradiol Transdermal System Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.1.4 Estradiol Transdermal System Product Introduction
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.2.4 Estradiol Transdermal System Product Introduction
11.2.5 Allergan Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.3.4 Estradiol Transdermal System Product Introduction
11.3.5 Bayer Recent Development
11.4 Noven Therapeutics
11.4.1 Noven Therapeutics Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.4.4 Estradiol Transdermal System Product Introduction
11.4.5 Noven Therapeutics Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.5.4 Estradiol Transdermal System Product Introduction
11.5.5 Mylan Recent Development
11.6 Vertical Pharmaceuticals
11.6.1 Vertical Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.6.4 Estradiol Transdermal System Product Introduction
11.6.5 Vertical Pharmaceuticals Recent Development
11.7 Perrigo Pharma International
11.7.1 Perrigo Pharma International Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.7.4 Estradiol Transdermal System Product Introduction
11.7.5 Perrigo Pharma International Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Estradiol Transdermal System Sales Channels
12.2.2 Estradiol Transdermal System Distributors
12.3 Estradiol Transdermal System Customers
13 Market Forecast
13.1 Global Estradiol Transdermal System Sales and Revenue Forecast 2018-2025
13.2 Global Estradiol Transdermal System Sales Forecast by Type
13.3 Global Estradiol Transdermal System Sales Forecast by Application
13.4 Estradiol Transdermal System Forecast by Regions
13.4.1 Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025
13.4.2 Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Estradiol Transdermal System Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Estradiol Transdermal System Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Estradiol Transdermal System Product Picture
Table Estradiol Transdermal System Key Market Segments
Table Major Manufacturers Estradiol Transdermal System Covered in This Report
Table Global Estradiol Transdermal System Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Estradiol Transdermal System Sales Market Shar by Type 2013-2025
Figure 0.025 mg per day Figures
Table Major Manufacturers of 0.025 mg per day
Figure 0.0375 mg per day Figures
Table Major Manufacturers of 0.0375 mg per day
Figure 0.05 mg per day Figures
Table Major Manufacturers of 0.05 mg per day
Figure 0.075 mg per day Figures
Table Major Manufacturers of 0.075 mg per day
Figure 0.1 mg per day Figures
Table Major Manufacturers of 0.1 mg per day
Table Global Estradiol Transdermal System Market Share by Application 2018-2025 (K Units)
Figure Hot flashes Use Case
Figure Prevention of postmenopausal osteoporosis Use Case
Figure Treatment of hypoestrogenism Use Case
Figure Moderate-to-severe vasomotor symptoms Use Case
Figure Others Use Case
Figure Estradiol Transdermal System Report Years Considered
Figure Global Estradiol Transdermal System Market Size 2013-2025 (Million US$)
Figure Global Estradiol Transdermal System Sales 2013-2018 (K Units)
Table Global Estradiol Transdermal System Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Estradiol Transdermal System Sales by Regions 2013-2018 (K Units)
Table Global Estradiol Transdermal System Sales Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Sales Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Sales Market Share by Regions in 2018
Table Global Estradiol Transdermal System Revenue by Regions 2013-2018 (Million US$)
Table Global Estradiol Transdermal System Revenue Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Revenue Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Estradiol Transdermal System Sales by Manufacturers (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Manufacturers (2013-2018)
Figure Global Estradiol Transdermal System Sales Share by Manufacturers in 2018
Table Estradiol Transdermal System Revenue by Manufacturers (2013-2018) (Million USD)
Table Estradiol Transdermal System Revenue Share by Manufacturers (2013-2018)
Figure Estradiol Transdermal System Value Share by Manufacturers in 2018
Table Global Estradiol Transdermal System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Estradiol Transdermal System Price (2013-2018) (USD/Unit)
Table Key Manufacturers Estradiol Transdermal System Plants/Factories Distribution
Table Key Manufacturers Estradiol Transdermal System Area Served
Table Date of Key Manufacturers Enter into Estradiol Transdermal System Market
Table Key Manufacturers Estradiol Transdermal System Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 0.025 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.0375 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.05 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.075 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.1 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Sales Market Share by Type in 2017
Table Global Estradiol Transdermal System Revenue by Type (2013-2018) (Million US$)
Table Global Estradiol Transdermal System Revenue Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Revenue Market Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Revenue Market Share by Type in 2017
Table Estradiol Transdermal System Price by Type 2013-2018 (USD/Unit)
Table Global Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Application (2013-2018)
Figure Global Sales Estradiol Transdermal System Market Share by Application (2013-2018)
Figure Global Sales Estradiol Transdermal System Market Share by Application in 2017
Figure North America Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure North America Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table North America Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure North America Estradiol Transdermal System Sales Market Share by Company in 2018
Table North America Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure North America Estradiol Transdermal System Market Share by Type in 2018
Table North America Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure North America Estradiol Transdermal System Market Share by Application in 2018
Table North America Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 North America Estradiol Transdermal System Sales Market Share by Countries
Table North America Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table North America Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Estradiol Transdermal System Revenue Market Share by Countries
Figure United States Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Canada Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Europe Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Europe Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Europe Estradiol Transdermal System Sales Market Share by Company in 2018
Table Europe Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Market Share by Type
Table Europe Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Market Share by Application
Table Europe Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Sales Market Share by Countries
Table Europe Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Europe Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure Europe Estradiol Transdermal System Revenue Market Share by Countries in 2018
Figure Germany Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure France Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure UK Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Italy Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Russia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Sales Market Share by Company in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Market Share by Type in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Market Share by Application in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Estradiol Transdermal System Sales Market Share by Countries
Table Asia Pacific Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Estradiol Transdermal System Revenue Market Share by Countries
Figure China Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure China Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Japan Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Korea Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure India Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure India Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Australia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Central & South America Estradiol Transdermal System Sales Market Share by Company in 2018
Table Central & South America Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Central & South America Estradiol Transdermal System Market Share by Type in 2018
Table Central & South America Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure Central & South America Estradiol Transdermal System Market Share by Application in 2018
Table Central & South America Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure Central & South America Estradiol Transdermal System Sales Market Share by Countries in 2018
Table Central & South America Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure Central & South America Estradiol Transdermal System Revenue Market Share by Countries in 2018
Figure Brazil Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Market Share by Type
Table Middle East and Africa Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Market Share by Application
Table Middle East and Africa Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Sales Market Share by Countries
Table Middle East and Africa Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Revenue Market Share by Countries
Figure GCC Countries Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Novartis Estradiol Transdermal System Sales Market Share in Global Market
Table Novartis Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Allergan Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Allergan Estradiol Transdermal System Sales Market Share in Global Market
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Bayer Estradiol Transdermal System Sales Market Share in Global Market
Table Bayer Recent Development
Table Noven Therapeutics Company Details
Table Noven Therapeutics Description and Business Overview
Table Noven Therapeutics Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Noven Therapeutics Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Noven Therapeutics Estradiol Transdermal System Sales Market Share in Global Market
Table Noven Therapeutics Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Mylan Estradiol Transdermal System Sales Market Share in Global Market
Table Mylan Recent Development
Table Vertical Pharmaceuticals Company Details
Table Vertical Pharmaceuticals Description and Business Overview
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales Market Share in Global Market
Table Vertical Pharmaceuticals Recent Development
Table Perrigo Pharma International Company Details
Table Perrigo Pharma International Description and Business Overview
Table Perrigo Pharma International Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Perrigo Pharma International Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Perrigo Pharma International Estradiol Transdermal System Sales Market Share in Global Market
Table Perrigo Pharma International Recent Development
Figure Estradiol Transdermal System Value Chain
Table Estradiol Transdermal System Distributors List
Table Estradiol Transdermal System Customers List
Table Global Estradiol Transdermal System Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Revenue Forecast 2018-2025 (Million US$)
Table Global Estradiol Transdermal System Sales Forecast by Type 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Type 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Type 2018-2025
Table Global Estradiol Transdermal System Sales Forecast by Application 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Application 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Application 2018-2025
Table Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Regions 2018-2025
Table Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Estradiol Transdermal System Revenue Market Share Forecast by Regions 2018-2025
Table North America Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table North America Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table North America Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure United States Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Canada Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure MexicoEstradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Europe Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Europe Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure France Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure UK Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Italy Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Russia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure China Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Japan Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Korea Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure India Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Australia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Indonesia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Thailand Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Malaysia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Philippines Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Vietnam Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Central & South America Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Estradiol Transdermal System Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
Novartis、Allergan、Bayer、Noven Therapeutics、Mylan、Vertical Pharmaceuticals、Perrigo Pharma International